Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IG3-H5253 | Human | Human IGFBP-3 (28-291) Protein, Fc Tag |  |
|
|
| IG3-H52H9 | Human | Human IGFBP-3 Protein, His Tag |  |
|
|
Immobilized Biotinylated Human IGF-II, Avitag,Fc Tag (Cat. No. IG2-H82F9) at 2 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (1 μg/well) plate can bind Human IGFBP-3, His Tag (Cat. No. IG3-H52H9) with a linear range of 0.01-0.313 μg/mL (QC tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Mecasermin Rinfabate | rhIGF-I/rhIGFBP-3; TAK-607; OHB-607; IGF-I/IGFBP-3; SHP-607; HGT-ROP-001 | Phase 2 Clinical | Insmed | Noonan Syndrome; Failure to Thrive; Cerebral Intraventricular Hemorrhage; Lung Diseases; Myotonic Dystrophy; Bronchopulmonary Dysplasia; Retinopathy of Prematurity; Laron Syndrome | Details |
| ENT-001 | Ent-001; ENT-001; Ent001 | Phase 1 Clinical | Ospedale San Raffaele | Diabetes Mellitus, Type 1; Inflammatory Bowel Diseases | Details |
This web search service is supported by Google Inc.
A-Z
